Future Best Buys Can and Should Do More; Comment on “Barriers and Opportunities for WHO ‘Best Buys’ Non-Communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review”

Document Type : Commentary

Authors

1 Berman Institute of Bioethics, Johns Hopkins University, Baltimore, MD, USA

2 Centre for the Programme of Aids Research in South Africa, University of KwaZulu-Natal, Durban, South Africa

3 Ethox Centre, Oxford University, Oxford, UK

Abstract

Over a decade has passed since the World Health Organisation proposed a set of “best buys” for the prevention of non-communicable disease (NCDs). Loffreda et al’s review describes how, despite the cost-effectiveness of these interventions, their adoption is often complex and governments face many challenges in both implementing and maintaining NCD prevention policies. Industry opposition and the commercial determinants of health remain significant challenges to an effective NCD response. In addition, the best buys may operate inequitably and are often unable to respond to the interrelated challenges posed by the global syndemic of obesity. We suggest that the next revision of the best buys adopts a more integrated approach that prioritize structural interventions, equity-focused strategies, and mechanisms to counteract industry interference. 

Keywords



Articles in Press, Accepted Manuscript
Available Online from 14 May 2025
  • Receive Date: 20 February 2025
  • Revise Date: 07 May 2025
  • Accept Date: 11 May 2025
  • First Publish Date: 14 May 2025